Users Coming Off Anti-Obesity Jabs Put On Pounds Four Times Faster Than Dieters

A recent study indicates that patients who stop using new weight-loss injections like Mounjaro or Wegovy can put back on lost weight far faster than those who halt conventional diet and exercise plans.

Published data in a leading medical journal points out that while obese people often shed a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.

"Users using these drugs need to be informed of the potential of rapid rebound weight gain when the medication ends," stated lead investigator Dr. Susan Jebb.

That rate of regain implies a reversion to pre-treatment mass in about 18 months.

Comparing Therapies

The research, which looked at dozens of trials involving thousands of patients, contrasted the results of the injectable medications with older methods.

Scientists note that people who lose weight through dieting usually have a slower weight regain—around 100 grams monthly—after stopping.

Understanding the Rapid Regain

Doctors believe the mechanism of the jabs is key to understanding the heightened weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to produce less of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement leads to hunger is unsuppressed, making excessive eating far more likely."

A Chronic Condition?

The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Many experts contend that, given the high risk of weight regain, the treatment is often long-term.

This opinion is reinforced by drug manufacturers, who state that the results "highlight the long-term nature of obesity," similar to managing conditions like diabetes.

User Accounts

People who have stopped the jabs explain a intense resurgence of hunger.

"It felt as if something that goes on and you become ravenous," said a patient.

The struggle is compounded if individuals have not established permanent dietary or behavioural modifications during treatment.

Significant Use

Survey data show that millions of adults in the UK have used weight-loss jabs in the past year, with interest being substantial.

• Adoption is more common among females compared to males.
• The middle-aged demographic shows the highest level of interest.
• Many obtain the drugs through private prescriptions rather than public health services.

Ultimately, researchers stress that while these medications are effective agents for shedding pounds, they are not a standalone solution and maintained weight loss relies on ongoing lifestyle management.